Novel Spirotetracyclic Zwitterionic Dual H1/5-HT2A Receptor Antagonists for the Treatment of Sleep Disorders

Author:

Gianotti Massimo1,Botta Maurizio2,Brough Stephen3,Carletti Renzo1,Castiglioni Emiliano1,Corti Corrado1,Dal-Cin Michele1,Delle Fratte Sonia1,Korajac Denana4,Lovric Marija4,Merlo Giancarlo1,Mesic Milan4,Pavone Francesca1,Piccoli Laura1,Rast Slavko4,Roscic Maja4,Sava Anna1,Smehil Mario4,Stasi Luigi1,Togninelli Andrea2,Wigglesworth Mark J.3

Affiliation:

1. Neurosciences CEDD, GlaxoSmithKline, Medicines Research Centre, Via A. Fleming 4, 37135 Verona, Italy

2. Dipartimento Farmaco Chimico Tecnologico, Universitá degli Studi di Siena, Via Aldo Moro 2, I-53100 Siena, Italy

3. GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, U.K.

4. Integrated Research Unit, IRU Chemistry, Prilaz Baruna Filipovica 29, 10000 Zagreb, Croatia

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Reference36 articles.

1. National Sleep Foundation. Sleep in America Poll Highlight & Key Findings.http://www.sleepfoundation.org/, 2010.

2. Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time

3. Epidemiology of insomnia: what we know and what we still need to learn

4. Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults

5. Sleep Disorders in the Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR,4th ed.American Psychiatric Association:Arlington, VA, 2000; pp597−661.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3